147 related articles for article (PubMed ID: 37888582)
1. Prurigo-like atopic dermatitis in a child with CARD11-associated severe combined immunodeficiency successfully treated with dupilumab.
Gualdi G; Lougaris V; Amerio P; Petruzzellis A; Parodi A; Burlando M
Pediatr Dermatol; 2024; 41(1):158-159. PubMed ID: 37888582
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of dupilumab for controlling severe atopic dermatitis with dominant-negative CARD11 variant.
Charvet E; Bourrat E; Hickman G; Donadieu J; Bellanné-Chantelot C; Jachiet M; Bouaziz JD; Bagot M; Cassius C
Clin Exp Dermatol; 2021 Oct; 46(7):1334-1335. PubMed ID: 33864281
[No Abstract] [Full Text] [Related]
3. Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature.
Magdaleno-Tapial J; Valenzuela-Oñate C; García-Legaz-Martínez M; Martínez-Domenech Á; Pérez-Ferriols A
Australas J Dermatol; 2020 May; 61(2):e223-e225. PubMed ID: 31766073
[TBL] [Abstract][Full Text] [Related]
4. Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response.
Husein-ElAhmed H; Steinhoff M
J Dermatolog Treat; 2022 May; 33(3):1547-1553. PubMed ID: 33200955
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Dupilumab for the Treatment of Generalized Prurigo Nodularis Phenotype of Adult Atopic Dermatitis.
Napolitano M; Fabbrocini G; Scalvenzi M; Nisticò SP; Dastoli S; Patruno C
Dermatitis; 2020; 31(1):81-84. PubMed ID: 31517666
[TBL] [Abstract][Full Text] [Related]
6. Severe atopic dermatitis in a 21-month-old boy successfully treated with dupilumab.
Mazzoni D; Lobo Y; Levitt D; Wheller L
Pediatr Dermatol; 2022 Jul; 39(4):606-608. PubMed ID: 35575257
[TBL] [Abstract][Full Text] [Related]
7. [THREE CASES OF ATOPIC DERMATITIS CHILDREN WITH INTRACTABLE PRURIGO NODULARIS].
Murakami Y; Sugiyama A; Ideguchi H; Murakami Y; Amimoto Y; Nishie H; Odajima H
Arerugi; 2020; 69(3):213-217. PubMed ID: 32435023
[TBL] [Abstract][Full Text] [Related]
8. Dupilumab in Inflammatory Skin Diseases: A Systematic Review.
Olbrich H; Sadik CD; Ludwig RJ; Thaçi D; Boch K
Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189381
[TBL] [Abstract][Full Text] [Related]
9. Safety of dupilumab in a 5-month-old infant with severe atopic dermatitis.
Havele SA; Khurana MC; McMahon P; Murthy AS; Perman MJ; Treat JR
Pediatr Dermatol; 2022 Mar; 39(2):291-294. PubMed ID: 35434859
[TBL] [Abstract][Full Text] [Related]
10. Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children.
Fang H; Zhang F; Lin W; Jiang Y; Liu Q; Yang D
Front Immunol; 2024; 15():1395288. PubMed ID: 38903518
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
Blauvelt A; Guttman-Yassky E; Paller AS; Simpson EL; Cork MJ; Weisman J; Browning J; Soong W; Sun X; Chen Z; Kosloski MP; Kamal MA; Delevry D; Chuang CC; O'Malley JT; Bansal A
Am J Clin Dermatol; 2022 May; 23(3):365-383. PubMed ID: 35567671
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Dupilumab in Pediatric Patient With Prurigo Nodularis-Like Atopic Dermatitis.
Yiling Y; Ali K; Jiayang D; Qiu Y; Kai G; JinPeng S; Tianci X; Min C; Menghua L; Liming W
Dermatitis; 2023; 34(2):162-163. PubMed ID: 36917530
[No Abstract] [Full Text] [Related]
13. [Hair growth with dupilumab in alopecia areata universalis and atopic dermatitis].
Reinhold L; Lange K; Lindhof H; Homey B; Firouzi-Memarpuri P
Dermatologie (Heidelb); 2022 Jul; 73(7):556-559. PubMed ID: 34609537
[TBL] [Abstract][Full Text] [Related]
14. Clinical remission of disseminated molluscum contagiosum infection in a patient with atopic dermatitis treated with dupilumab.
Elosua-González M; Rosell-Díaz Á; Alfageme-Roldán F; Sigüenza-Sanz M; Roustan-Gullón G
An Bras Dermatol; 2022; 97(3):358-361. PubMed ID: 35307242
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of Alopecia Areata After Dupilumab Therapy for Atopic Dermatitis.
Carnicle JM; Hendricks AJ; Shi VY
Dermatitis; 2021 Oct; 32(1S):e80-e82. PubMed ID: 31441782
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous effectiveness of dupilumab in atopic dermatitis and alopecia areata in two patients.
Ludriksone L; Elsner P; Schliemann S
J Dtsch Dermatol Ges; 2019 Dec; 17(12):1278-1280. PubMed ID: 31829527
[No Abstract] [Full Text] [Related]
17. Dupilumab shows slow, steady effectiveness for intractable prurigo in patients with atopic dermatitis.
Takeuchi S; Inoue K; Kuretake K; Kiyomatsu-Oda M; Furue M
J Dermatol; 2021 May; 48(5):638-644. PubMed ID: 33742710
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of dupilumab in chronic prurigo and chronic idiopathic pruritus: a systematic review of current evidence and analysis of response predictors.
Gael M; Adam T; Mariano-Bourin M; Bursztejn AC
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1541-1551. PubMed ID: 35569006
[TBL] [Abstract][Full Text] [Related]
19. Dupilumab as a useful treatment option for prurigo nodularis in an elderly patient with atopic diathesis.
Criado PR; Pincelli TP; Criado RFJ
Int J Dermatol; 2020 Oct; 59(10):e358-e361. PubMed ID: 32562425
[No Abstract] [Full Text] [Related]
20. Long-Term Efficacy of Dupilumab in Alopecia Areata.
Kulkarni M; Rohan CA; Travers JB; Serrao R
Am J Case Rep; 2022 Jun; 23():e936488. PubMed ID: 35726185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
